Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
147.59
+1.82 (1.25%)
Nov 20, 2026, 11:45 AM EST - Market open
Palvella Therapeutics Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Palvella Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $233.44. The average 1-year stock price forecast is 58.17% higher than the current stock price, while the lowest is $207 (+40.25%) and the highest is $267 (+80.91%).
Price Target: $233.44 (+58.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Palvella Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 15 | 15 | 15 | 16 | 17 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $246 | Buy | Reiterates | $246 | +66.68% | Nov 20, 2026 |
| BTIG | BTIG | Buy Maintains $215 | Buy | Maintains | $215 | +45.67% | Nov 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $232 | Buy | Reiterates | $232 | +57.19% | Nov 20, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Initiates $228 | Buy | Initiates | $228 | +54.48% | Nov 16, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $232 → $243 | Buy | Reiterates | $232 → $243 | +64.65% | Nov 9, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
22.85M
EPS This Year
-6.25
from -3.71
EPS Next Year
-7.61
from -6.25
EPS and Forward PE are based on non-GAAP adjusted numbers.